Identification of Atg-8–Atg 3 protein-protein interaction inhibitor
Jürgen Bosch, Johns Hopkins University, speaking at Drug Discovery and Development 2014
Rising Role of Academic Drug Discovery
Barbara Slusher, Johns Hopkins University School of Medicine, speaking at Drug Discovery and Development 2014.
Diversity Orientated Synthesis
Andrea Trabocchi, University of Florence, speaking at Drug Discovery and Development 2014
Science for Life Laboratory Drug Discovery & Development Platform
Per Arvidson, Karolinska Institute, speaking at Drug Discovery and Development 2014
Continuous Flow Synthesis of alpha-Haloketones – Essential Building Blocks of Antiretroviral Agents
Oliver Kappe, Karl Franzens University of Graz, speaking at Flow Chemistry Congress 2014
Catalysis in Flow: Operando Study of Pd Catalyst Speciation and Leaching
Mimi Hii, Imperial College, speaking at Flow Chemistry Congress 2014.
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart
Drug-drug combinations made simple
Roderick L. Beijersbergen, Associate Professor Division of Molecular Carcinogenesis and Head NKI Robotics and Screening Center.
Druggability of Dynamic Protein-Protein Interfaces
Volkhard Helms, Universitat des Saarlandes, speaking at Discovery Chemistry Congress 2013.
Library Design for Tackling Protein-protein Interactions: The 2P2I Approach
Dr Philippe Roche, CNRS, speaking at Discovery Chemistry Congress 2013.
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 132|